Enzyme PapB could boost longevity and potency of Ozempic-like weight‑loss drugs
Scientists at the University of Utah found that the enzyme PapB can macrocyclize GLP-1–like drug peptides, increasing their stability and duration in the body, potentially making Ozempic/Wegovy‑type weight‑loss drugs more potent and longer‑lasting.